Zhejiang Yatai Pharmaceutical Co Ltd (002370.SZ) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · China · ISIN CNE100000MM5
Zhejiang Yatai Pharmaceutical Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 405.17 m CNY | 323.14 m CNY |
| Gross profit | 120.75 m CNY | 107.00 m CNY |
| Operating income | 28.16 m CNY | -12.24 m CNY |
| EBIT | 65.08 m CNY | 131.14 m CNY |
| Net income | 34.24 m CNY | 96.31 m CNY |
| Diluted EPS – continuing operations | 0.05 CNY | 0.13 CNY |
Full history since 2006, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Zhejiang Yatai Pharmaceutical Co Ltd
Zhejiang Yatai Pharmaceutical Co., Ltd. researches, produces, sells, and exports pharmaceutical products in China and internationally. The company offers solid dosage, cephalosporin powder injection, and freeze-dried powder injection products. It also provides antibiotic and non-antibiotic drugs. The company was founded in 1989 and is based in Shaoxing, China.
More stocks
- Henan Newland Pharmaceutical Co. Ltd. A (301277.SZ)
- Ningbo Solartron Technology Co Ltd (688299.SS)
- First Farmers Financial Corp (FFMR)
- S&S TECH Corporation (101490.KQ)
- Zhejiang Jinghua Laser Technology Co Ltd Class A (603607.SS)
- MORELD AS (MORLD.OL)
- HYSTER-YALE, INC. (HY)
- IVU Traffic Technologies (IVU.DE)
- TaiMed Biologics (4147.TWO)
- Comp SA (CMP.WA)
- Lucky Strike Entertainment Corp (LUCK)
- Hubei Xiangyuan New Material Technology Inc. (300980.SZ)
Not investment advice. All data without warranty, price as of 09.11.2026. Details in the risk notice.